Literature DB >> 30219840

SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases.

Subodh Kumar Mishra1, Neha Jain1, Uma Shankar1, Arpita Tawani1, Amit Mishra2, Amit Kumar1.   

Abstract

High-throughput screening and better understanding of small molecule's structure-activity relationship (SAR) using computational biology techniques have greatly expanded the face of drug discovery process in better discovery of therapeutics for various disease. Small Molecule Modulators Database (SMMDB) includes >1100 small molecules that have been either approved by US Food and Drug Administration, are under investigation or were rejected in clinical trial for any kind of neurological diseases. The comprehensive information about small molecules includes the details about their molecular targets (such as protein or enzyme, DNA, RNA, antisense RNA etc.), pharmacokinetic and pharmacodynamic properties such as binding affinity to their targets (Kd, Ki, IC50 and EC50 if available), mode of action, log P-value, number of hydrogen bond donor and acceptors, their clinical trial status, their 2D and three-dimensional structures etc. To enrich the basic annotation of every small molecule entry present in SMMDB, it is hyperlinked to their description present in PubChem, DrugBank, PubMed and KEGG database. The annotation about their molecular targets was enriched by linking it with UniProt and GenBank and STRING database that can be utilized to study the interaction and relation between various targets involved in single neurological disease. All molecules present in the SMMDB are made available to download in single file and can be further used in establishing the SAR, structure-based drug designing as well as shape-based virtual screening for developing the novel therapeutics against neurological diseases. The scope of this database majorly covers the interest of scientific community and researchers who are engaged in putting their endeavor toward therapeutic development and investigating the pathogenic mechanism of various neurological diseases. The graphical user interface of the SMMDB is accessible on http://bsbe.iiti.ac.in/bsbe/smmdb.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30219840      PMCID: PMC6146116          DOI: 10.1093/database/bay082

Source DB:  PubMed          Journal:  Database (Oxford)        ISSN: 1758-0463            Impact factor:   3.451


  49 in total

1.  Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI).

Authors:  Juswinder Singh; Claudio E Chuaqui; P Ann Boriack-Sjodin; Wen Cherng Lee; Timothy Pontz; Michael J Corbley; H-Kam Cheung; Robert M Arduini; Jonathan N Mead; Miki N Newman; James L Papadatos; Scott Bowes; Serene Josiah; Leona E Ling
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

3.  The synapse: center stage for many brain diseases.

Authors:  Christian Lüscher; John T Isaac
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

Review 4.  Understanding the molecular basis of fragile X syndrome.

Authors:  P Jin; S T Warren
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

Review 5.  Understanding neurological disease mechanisms in the era of epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

Review 6.  Mechanisms of disease: DNA repair defects and neurological disease.

Authors:  Kalluri Subba Rao
Journal:  Nat Clin Pract Neurol       Date:  2007-03

7.  An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.

Authors:  Monica Boselli; Byung-Hoon Lee; Jessica Robert; Miguel A Prado; Sang-Won Min; Chialin Cheng; M Catarina Silva; Changhyun Seong; Suzanne Elsasser; Ketki M Hatle; Timothy C Gahman; Steven P Gygi; Stephen J Haggarty; Li Gan; Randall W King; Daniel Finley
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

8.  JSME: a free molecule editor in JavaScript.

Authors:  Bruno Bienfait; Peter Ertl
Journal:  J Cheminform       Date:  2013-05-21       Impact factor: 5.514

Review 9.  Repeat-associated non-ATG (RAN) translation in neurological disease.

Authors:  John D Cleary; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2013-08-04       Impact factor: 6.150

10.  Shape based virtual screening and molecular docking towards designing novel pancreatic lipase inhibitors.

Authors:  Ganesh Kumar Veeramachaneni; K Kranthi Raj; Leela Madhuri Chalasani; Sai Krishna Annamraju; Bondili Js; Venkateswara Rao Talluri
Journal:  Bioinformation       Date:  2015-12-31
View more
  1 in total

1.  MST and TRIC Technology to Reliably Study PROTAC Binary and Ternary Binding in Drug Development.

Authors:  Tanja Bartoschik; Andreas Zoephel; Klaus Rumpel; Alessio Ciulli; Charles Heffern
Journal:  Methods Mol Biol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.